Valuation: ALTEOGEN Inc.

Market Cap 16,069B 10.64B 9.31B 8.59B 7.94B 15.08B 1,016B 15.33B 103B 40.31B 499B 39.96B 39.09B 1,728B P/E 2026 *
54.9x
P/E 2027 * 36.8x
Enterprise Value 15.57B 10.31M 9.02M 8.32M 7.7M 14.61M 984M 14.85M 99.63M 39.06M 483M 38.72M 37.88M 1.67B EV / Sales 2026 *
33.2x
EV / Sales 2027 * 22.7x
Free-Float
74.26%
Yield 2026 *
0.17%
Yield 2027 * 0.18%
1 day-4.31%
1 week-16.20%
Current month-16.90%
1 month+3.63%
3 months-19.89%
6 months-37.30%
Current year-33.26%
1 week 300,000
Extreme 300000
359,000
1 month 299,500
Extreme 299500
397,500
Current year 286,000
Extreme 286000
529,000
1 year 286,000
Extreme 286000
569,000
3 years 38,000
Extreme 38000
569,000
5 years 27,875
Extreme 27875
569,000
10 years 3,645.83
Extreme 3645.8333
569,000
Manager TitleAgeSince
Chief Executive Officer 60 2025-12-25
Director of Finance/CFO 61 2023-03-27
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 2008-05-12
Director/Board Member 70 2021-03-28
Director/Board Member 61 2023-03-27
Date Insider Type Main position Quantity % Market Cap.
25-05-20Fiscal year

Chief Executive Officer

7,200 0.0135%
24-03-26Sell 1,600,000 3.0182%
24-01-04Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-4.31%-16.20%-28.40%+677.20% 11.12B
+0.51%+1.94%+20.70%-5.18% 67.44B
+0.52%-5.52%+46.80%+218.71% 53.98B
-2.79%+32.50%+32.50%+32.50% 41.77B
+0.99%+6.05%-48.96%-52.97% 41.15B
-0.38%-7.41%+50.43%-28.94% 29.58B
+2.68%-5.39%+130.13%-38.70% 29.28B
+0.58%+1.17%+72.04%+91.02% 23.43B
+0.17%+8.48%+4.86%+185.45% 19.11B
+1.14%-0.17%+68.83%+134.48% 16.82B
Average -0.09%-0.05%+34.89%+121.36% 33.37B
Weighted average by Cap. +0.12%+0.61%+33.53%+72.26%

Financials

2026 *2027 *
Net sales 469B 310M 272M 250M 232M 440M 29.64B 447M 3B 1.18B 14.55B 1.17B 1.14B 50.41B 672B 445M 389M 359M 332M 631M 42.49B 641M 4.3B 1.69B 20.87B 1.67B 1.64B 72.28B
Net income 311B 206M 180M 166M 154M 292M 19.64B 296M 1.99B 779M 9.65B 772M 756M 33.41B 397B 263M 230M 212M 196M 372M 25.07B 378M 2.54B 995M 12.31B 986M 965M 42.65B
Net Debt -499B -330M -289M -267M -247M -468M -31.54B -476M -3.19B -1.25B -15.49B -1.24B -1.21B -53.64B -828B -548M -480M -442M -409M -777M -52.33B -790M -5.3B -2.08B -25.7B -2.06B -2.01B -89.01B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
26-07-08 300,000.00 -4.31% 483,782
26-07-08 ₩313,500.00 -7.11% 452,829
26-07-07 ₩337,500.00 +1.96% 355,590
26-07-06 ₩331,000.00 -3.07% 266,040
26-07-03 ₩341,500.00 -2.84% 439,497
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
300,000.00KRW
Average target price
458,000.00KRW
Spread / Average Target
+52.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock